Faculty profile

Michael Yan

ResearcherUniversity of Toronto

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Toronto directory, so their courses and email address may be missing. Find their university profile.

Michael Yan

Researcher

Health Sciences

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
44 publications in the last five years, latest in 2026.
Senior (last) author on 6 recent papers, a sign of leading a research group.
Principal investigator on 2 research grants (2 CIHR), most recently in 2025.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Hepatocellular Carcinoma

Latest papers

Risk prediction model for brain metastasis risk among patients diagnosed with primary gastrointestinal cancers.
British journal of cancer · 2026 · senior author
Ultra-high dose radiation for Liver metastasis using MR-guided TReatment with stereotactic Ablative Single-fraction (ULTRAS): study protocol for a phase III randomized controlled trial.
Contemporary clinical trials · 2026
Overall Survival Among Patients With Hepatocellular Carcinoma Treated With External Beam Radiation Therapy: Individual Patient Data Outcomes From a Multinational Cohort.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2026

All 45 publications

Latest funding

A randomised controlled trial of Standard Of Care versus RadioAblaTion in Early Stage HCC (The SOCRATES HCC Study)
CIHR · 2025 · Nominated PI
$25,000
A randomised controlled trial of Standard Of Care versus RadioAblaTion in Early Stage HCC (The SOCRATES HCC Study)
CIHR · 2025 · Nominated PI
$210,000

All 2 grants and awards

45 publications.

Risk prediction model for brain metastasis risk among patients diagnosed with primary gastrointestinal cancers.

Barcelona MVN, Kataki KJ, Rahman FA, Moraes FY, Millar BA, Conrad T, Keilty D, Hope A, Sun A, Kongkham P, Elimova E, Deng Y, Shultz D, Yan M

British journal of cancer2026Senior author

DOI: 10.1038/s41416-026-03587-8 PMID: 42649380

Ultra-high dose radiation for Liver metastasis using MR-guided TReatment with stereotactic Ablative Single-fraction (ULTRAS): study protocol for a phase III randomized controlled trial.

Wong H, Ng SSW, Mohamad I, Alborz J, Stanescu T, Liu ZA, De Leon J, Tan H, Ng SP, Radhakrishna G, Bahij R, Intven M, Kirichenko A, Mesci A, Yan M, Dawson L, Augilera T, Hosni A

Contemporary clinical trials2026

DOI: 10.1016/j.cct.2026.108381 PMID: 42309387

Overall Survival Among Patients With Hepatocellular Carcinoma Treated With External Beam Radiation Therapy: Individual Patient Data Outcomes From a Multinational Cohort.

Moon AM, Yanagihara TK, Dawson LA, Yu JI, Lawrence TS, Kim TH, Yan M, Iwata H, Nabavizadeh N, Apisarnthanarax S, Dunne EM, Lock MI, Chuong MD, Chiang CL, Scorsetti M, Katoh N, Sioshansi S, Numata K, Liu HY, Iwamoto H, Wakatsuki M, Chen Y, Pollom EL, Gkika E, Jabbour SK, Munoz-Schuffenegger P, Dutta D, Hajj C, Ueno M, Hallemeier CL, Feldman AM, Méndèz Romero A, Tan X, Molla M, Tepper JE, Torres F, Reig M, EBRT Collaboration Group

Journal of clinical oncology : official journal of the American Society of Clinical Oncology2026

DOI: 10.1200/jco-25-02399 PMID: 42139645

Never Say Never: Another Opportunity for Curative-Intent Preoperative Pelvic Reirradiation.

Kim I, Yan M

International journal of radiation oncology, biology, physics2026Senior author

DOI: 10.1016/j.ijrobp.2026.01.048 PMID: 42586123

The role of stereotactic body radiotherapy in oligoprogressive breast cancer: A site-specific analysis of the prospective, phase-II RADIANT trial.

Ruicci KM, Helou J, Barry A, Ye XY, Koch CA, Croke J, Han K, Rodin D, Hahn E, Kwan JYY, Yan M, Liu FF, Lindsay P, Javor J, Bedard P, Cescon D, Kumar V, Amir E, Nadler MB, Lee R, Glicksman RM

Clinical and translational radiation oncology2026

DOI: 10.1016/j.ctro.2026.101164 PMID: 42011409

Salvage Radiotherapy in Isolated Locoregional Recurrence of Pancreatic Adenocarcinoma Post-Radical Surgical Resection: Prudent or Pointless? A Retrospective Comparative Analysis.

Faulkner C, Erjan A, Mheid S, Yan M, Shwaartz CG, Tsang E, Kalimuthu S, Stanescu T, Hosni A, Mesci A

Current oncology (Toronto, Ont.)2026

DOI: 10.3390/curroncol33060337 PMID: 42346237

Clinical and molecular features associated with the presence of brain metastases and survival in patients with advanced thyroid cancer.

Barron CC, Megid TBC, Deng Y, Sugumar V, Ladak S, Mesci A, Yan M, Lukovic J, Krzyzanowska MK, Sawka AM, Mete O, Ma LX

The oncologist2026

DOI: 10.1093/oncolo/oyag211 PMID: 42213058

Duration of systemic therapy in patients with metastatic EGFR-mutated non-small cell lung cancer and brain metastases.

Yan M, Tjong M, Coburn N, Nguyen L, Sahgal A, Louie AV, Parmar A

Translational lung cancer research2026First author

DOI: 10.21037/tlcr-2026-1-0107 PMID: 42291352

Health-Related Quality of Life After SBRT for Oligoprogressive Disease: Results From a Phase II Prospective Trial.

Helou J, Glicksman R, Bezjak A, Raman S, Chen E, Chung P, Dawson LA, Hope A, Hosni A, Javor J, Lindsay P, Yan M, Wong R, Ye XY, Barry A

International journal of radiation oncology, biology, physics2026

DOI: 10.1016/j.ijrobp.2025.12.070 PMID: 41547376

Prospective evaluation of liver cancer volumes on non-contrast 1.5 T MR Linac imaging.

Glynn AM, Saha S, Gerard IJ, Velec M, Stanescu T, Martinez JD, Munoz-Schuffenegger P, Hosni A, Mesci A, Yan M, Rocca C, Shessel A, Kim TK, Dawson LA

Clinical and translational radiation oncology2026

DOI: 10.1016/j.ctro.2026.101110 PMID: 41631035

Something wrong or missing on this profile? Suggest a correction

Michael Yan

Research

Latest papers

Latest funding

Risk prediction model for brain metastasis risk among patients diagnosed with primary gastrointestinal cancers.

Ultra-high dose radiation for Liver metastasis using MR-guided TReatment with stereotactic Ablative Single-fraction (ULTRAS): study protocol for a phase III randomized controlled trial.

Overall Survival Among Patients With Hepatocellular Carcinoma Treated With External Beam Radiation Therapy: Individual Patient Data Outcomes From a Multinational Cohort.

Never Say Never: Another Opportunity for Curative-Intent Preoperative Pelvic Reirradiation.

The role of stereotactic body radiotherapy in oligoprogressive breast cancer: A site-specific analysis of the prospective, phase-II RADIANT trial.

Salvage Radiotherapy in Isolated Locoregional Recurrence of Pancreatic Adenocarcinoma Post-Radical Surgical Resection: Prudent or Pointless? A Retrospective Comparative Analysis.

Clinical and molecular features associated with the presence of brain metastases and survival in patients with advanced thyroid cancer.

Duration of systemic therapy in patients with metastatic EGFR-mutated non-small cell lung cancer and brain metastases.

Health-Related Quality of Life After SBRT for Oligoprogressive Disease: Results From a Phase II Prospective Trial.

Prospective evaluation of liver cancer volumes on non-contrast 1.5&#xa0;T MR Linac imaging.

A randomised controlled trial of Standard Of Care versus RadioAblaTion in Early Stage HCC (The SOCRATES HCC Study)

A randomised controlled trial of Standard Of Care versus RadioAblaTion in Early Stage HCC (The SOCRATES HCC Study)

Frequent collaborators

Teodor Stanescu

Arjun Sahgal

Jelena Lukovic

Julie Hallet

John Kim

Andrew Hope

Gonzalo Sapisochin

Alejandro Berlin

Laura Dawson

Paul Wheatley-Price

Jennifer Croke

Sunit Das

Gelareh Zadeh

Arndt Vogel

Chinthaka Heyn

Philip Wong

Geoffrey Liu

Nir Lipsman

Ian Mcgilvray

Alyson Mahar

Robert Grant

Philippe Bedard

Breffni Hannon

Elena Elimova

Prospective evaluation of liver cancer volumes on non-contrast 1.5 T MR Linac imaging.